Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sequoia sempervirens pollen is a biologic allergenic extract derived from the pollen of the coast redwood tree. It is primarily utilized by clinicians for the diagnosis and treatment of IgE-mediated allergic reactions to redwood pollen, which is prevalent in the Pacific Northwest regions of the United States. The extract is typically administered via subcutaneous injection for immunotherapy or used in skin prick testing for diagnostic purposes. Its mechanism of action involves modulating the immune system's response to specific allergens, potentially inducing desensitization through repeated exposure in a controlled clinical setting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sequoia sempervirens pollen.